Oscar Health (NYSE:OSCR) Stock Price Up 11.6% – Time to Buy?

Oscar Health, Inc. (NYSE:OSCR) shares were up 11.6% during mid-day trading on Tuesday . The stock traded as high as $17.90 and last traded at $17.83. Approximately 1,145,058 shares traded hands during trading, a decline of 66% from the average daily volume of 3,378,965 shares. The stock had previously closed at $15.98.

Analyst Ratings Changes

Several equities analysts recently issued reports on OSCR shares. Piper Sandler restated an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target on the stock. Finally, Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Price Performance

The company has a fifty day moving average price of $18.11 and a 200-day moving average price of $18.25. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same period in the previous year, the business posted ($0.29) earnings per share. The firm’s revenue was up 68.3% on a year-over-year basis. Equities analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Insider Transactions at Oscar Health

In other news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 3.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were acquired at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the acquisition, the director now directly owns 5,452,081 shares of the company’s stock, valued at approximately $74,584,468.08. The trade was a 8.36 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 169,569 shares worth $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Hedge funds have recently modified their holdings of the business. Wealth Enhancement Advisory Services LLC raised its position in Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock valued at $255,000 after buying an additional 844 shares during the last quarter. American International Group Inc. raised its position in Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after buying an additional 1,009 shares during the last quarter. Summit Trail Advisors LLC grew its stake in Oscar Health by 5.4% in the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock valued at $329,000 after purchasing an additional 1,065 shares in the last quarter. KBC Group NV grew its stake in Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares in the last quarter. Finally, Arizona State Retirement System grew its stake in Oscar Health by 3.7% in the second quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after purchasing an additional 1,351 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.